Literature DB >> 20930205

Quadriceps myostatin expression in COPD.

W D-C Man, S A Natanek, J Riddoch-Contreras, A Lewis, G S Marsh, P R Kemp, M I Polkey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20930205      PMCID： PMC3039204          DOI： 10.1183/09031936.00032510

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

1.  Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.

Authors:  A C McPherron; A M Lawler; S J Lee
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Skeletal muscle adaptations to testosterone and resistance training in men with COPD.

Authors:  Michael I Lewis; Mario Fournier; Thomas W Storer; Shalender Bhasin; Janos Porszasz; Song-Guang Ren; Xiaoyu Da; Richard Casaburi
Journal:  J Appl Physiol (1985)       Date:  2007-08-02

4.  Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading.

Authors:  C J Carlson; F W Booth; S E Gordon
Journal:  Am J Physiol       Date:  1999-08

5.  Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.

Authors:  H Gilson; O Schakman; L Combaret; P Lause; L Grobet; D Attaix; J M Ketelslegers; J P Thissen
Journal:  Endocrinology       Date:  2006-10-12       Impact factor: 4.736

6.  Double muscling in cattle due to mutations in the myostatin gene.

Authors:  A C McPherron; S J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

7.  Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.

Authors:  Elisabeth B Swallow; Diana Reyes; Nicholas S Hopkinson; William D-C Man; Raphaël Porcher; Edward J Cetti; Alastair J Moore; John Moxham; Michael I Polkey
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

8.  A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.

Authors:  Kathryn R Wagner; James L Fleckenstein; Anthony A Amato; Richard J Barohn; Katharine Bushby; Diana M Escolar; Kevin M Flanigan; Alan Pestronk; Rabi Tawil; Gil I Wolfe; Michelle Eagle; Julaine M Florence; Wendy M King; Shree Pandya; Volker Straub; Paul Juneau; Kathleen Meyers; Cristina Csimma; Tracey Araujo; Robert Allen; Stephanie A Parsons; John M Wozney; Edward R Lavallie; Jerry R Mendell
Journal:  Ann Neurol       Date:  2008-05       Impact factor: 10.422

9.  A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans.

Authors:  E B Swallow; H R Gosker; K A Ward; A J Moore; M J Dayer; N S Hopkinson; A M W J Schols; J Moxham; M I Polkey
Journal:  J Appl Physiol (1985)       Date:  2007-06-14

10.  Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.

Authors:  Pamela J Plant; Dina Brooks; Marie Faughnan; Tanya Bayley; James Bain; Lianne Singer; Judy Correa; Dawn Pearce; Matthew Binnie; Jane Batt
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914
View more
  14 in total

Review 1.  Autophagic cellular responses to physical exercise in skeletal muscle.

Authors:  Bjorn T Tam; Parco M Siu
Journal:  Sports Med       Date:  2014-05       Impact factor: 11.136

Review 2.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

3.  Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.

Authors:  Michael I Polkey; Jens Praestgaard; Amy Berwick; Frits M E Franssen; Dave Singh; Michael C Steiner; Richard Casaburi; Hanns-Christian Tillmann; Estelle Lach-Trifilieff; Ronenn Roubenoff; Daniel S Rooks
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

Review 4.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 5.  Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases.

Authors:  Elena Abati; Arianna Manini; Giacomo Pietro Comi; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2022-06-21       Impact factor: 9.207

Review 6.  Muscle function in COPD: a complex interplay.

Authors:  Anna V Donaldson; Matthew Maddocks; Dario Martolini; Michael I Polkey; William D-C Man
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-17

7.  Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD.

Authors:  Amy Lewis; Joanna Riddoch-Contreras; Samantha A Natanek; Anna Donaldson; William D-C Man; John Moxham; Nicholas S Hopkinson; Michael I Polkey; Paul R Kemp
Journal:  Thorax       Date:  2011-10-13       Impact factor: 9.139

Review 8.  Structural alterations of skeletal muscle in copd.

Authors:  Sunita Mathur; Dina Brooks; Celso R F Carvalho
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

Review 9.  Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction.

Authors:  Se-Jin Lee
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 10.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.